Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General cellular components via ROS-mediated oxidation refers to the non-specific damage of vital biological macromolecules—including lipids, proteins, and nucleic acids—by reactive oxygen species (ROS) [1]. This process is a hallmark of oxidative stress, where an imbalance between ROS production and antioxidant defenses leads to cellular dysfunction and death [2]. In a therapeutic context, this mechanism is often exploited by pro-oxidant drugs, such as certain chemotherapeutics and photodynamic therapies, to induce apoptosis in malignant cells [3]. Conversely, many pathologies, including neurodegeneration and cardiovascular disease, are driven by chronic ROS-mediated damage, making the protection of these components a goal for antioxidant therapies [1]. Because this target encompasses nearly all structural and functional elements of a cell, drugs acting through this pathway often exhibit low specificity and significant side effects [4]. The lack of a single molecular site makes it a challenging focus for precision medicine, though it remains a potent tool in oncology and antimicrobial treatments [2]. Sources: [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249911/, [2] https://pubmed.ncbi.nlm.nih.gov/23626505/, [3] https://www.nature.com/articles/nrd3050, [4] https://pubchem.ncbi.nlm.nih.gov/compound/Hydrogen-peroxide.
Induction of oxidative stress through the generation of reactive oxygen species (ROS), which non-specifically oxidize lipids, proteins, and DNA, leading to structural damage and cell death.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cellular components via ROS-mediated oxidation.